|A constant threat|
DHSC will award up to £32m of capital funding to the NHS, universities and research organisations for research into antimicrobial resistance (AMR).
The purpose of this funding is to support capital investment in buildings (including refurbishment) & equipment to strengthen the UK’s AMR research capability in order to:
All NHS trusts, higher education institutions and not-for-profit UK research organisations (including the NHS and public sector agencies & research establishments) in the UK are eligible to apply. The closing date for applications is 1pm on 6 December 2018. More information is on NIHR’s website.Resistance to all antimicrobials, and especially bacterial resistance to existing antibiotics, is increasing. It is now posing a serious threat to health both in the UK & globally, and risks undermining the major improvements in medicine that have been made in recent decades.